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A fundamental objective of septic shock resuscitation 
is rapid restoration of tissue perfusion. However, one of 
the most crucial unresolved challenges is to identify a 
clinical physiological variable that closely reflects global 
or regional hypoperfusion, or cellular hypoxia, and thus 
could be potentially used as an accurate resuscitation 
target.
Since the first description of lactate levels in humans, 
hyperlactatemia has been traditionally considered as a 
signal of tissue hypoxia. Both experimental and clini-
cal studies have shown that a reduction in global oxygen 
delivery will ultimately result in a decrease in oxygen 
consumption. When oxygen demand remains stable, this 
decrease in oxygen consumption hallmarks the occur-
rence of tissue hypoxia and is associated with a sharp 
increase in lactate levels [1, 2].
However as lactate is a normal product of glucose 
metabolism, many other factors could increase lactate 
levels even in the presence of adequate oxygen supply. 
Probably the most confounding factor is adrenergic-
driven aerobic glycolysis triggered by stress situations. 
Circulatory failure is associated with significant sympa-
thetic activation resulting in increased muscle release of 
lactate as a systemic metabolic fuel [3]. Thus, persistent 
hyperlactatemia could simply be a marker of the severity 
of shock or stress rather than reflecting real impairment 
of tissue perfusion/oxygenation.
Other factors, particularly abnormal lactate clearance, 
may also contribute to hyperlactatemia in the presence of 
adequate perfusion, although the evidence is not uniform. 
Whereas Levraut et  al. [4] demonstrated that impaired 
clearance was a significant cause of mild hyperlactatemia 
in stable septic patients, Revelly et al. [5] demonstrated, 
with stable isotopes, that lactate clearance was not the 
main cause of hyperlactatemia. More recently, Tapia et al. 
[6] showed an almost negligible exogenous lactate clear-
ance in early experimental septic shock despite preserved 
liver perfusion and a concomitant normal clearance of 
the alcohol sugar sorbitol.
In summary, persistent hyperlactatemia may represent 
a state of physiological disequilibrium between increased 
production (either aerobic or anaerobic) and impaired 
clearance. In this sense, pursuing lactate normalization 
through further resuscitation with fluids or inotropes 
when other signs of tissue hypoperfusion have disap-
peared may expose the patient to the toxicity of over-
resuscitation without any clear benefit. This highlights 
one of the major dilemmas during shock resuscitation: 
when to consider that a persistent hyperlactatemia is still 
the consequence of inadequate perfusion. A couple of 
algorithms to address this question have been proposed 
and are based on multimodal perfusion monitoring. Per-
sistent hyperlactatemia but with normal central venous 
oxygen saturation (ScvO2), central venous-arterial pCO2 
gradient [P(cv-a)CO2], and peripheral perfusion may 
indicate a lower probability of residual hypoperfusion, 
although this needs to be confirmed by future studies.
In support of this idea, a recent study [7] suggested that 
the time course of lactate normalization during a suc-
cessful resuscitation follows a biphasic curve: an early 
rapid response (a flow-responsive phase) followed by 
a later slower recovery trend potentially explained by 
non-flow-dependent mechanisms (Fig.  1). Interestingly, 
some flow-responsive variables such as ScvO2, P(cv-a)
CO2, and capillary refill time (CRT) exhibited much 
higher normalization rates at 6 h than lactate. Only half 
of this cohort of survivors normalized lactate at 24  h. 
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Admittedly, other series found slower normalization of 
some of these variables, which highlights the interest of 
multimodal monitoring.
Some data tend to support that lactate-guided resus-
citation strategies should be associated with multimodal 
perfusion monitoring and be focused on the early phase. 
De Backer et al. demonstrated that early improvement of 
microcirculatory flow with dobutamine was associated 
with rapid decrease in lactate [8]. A recently published 
therapeutic algorithm focused on lactate-driven resus-
citation exclusively in the first 8  h of ICU management 
with a significant favorable impact on outcome [9]. A 
recent meta-analysis also showed that early resuscita-
tion was associated with improved outcome, whereas late 
treatment was not [10].
To add to the complexity, an important finding in the 
study by Jansen et al. [9] was that the time course of lac-
tate levels was identical in both the protocol and control 
group, although the treatment team had no access to lac-
tate levels in the control group. The differences in hemo-
dynamic management between the two groups were 
minor although in agreement with the pivotal study on 
early goal-directed therapy: more intensive treatment in 
the study period and less in the follow-up period for the 
protocol patients when compared to the control group 
patients. Although the survival was significantly bet-
ter in the protocol group this was not reflected by the 
changes in lactate levels, either in the study period (first 
8  h) or in the follow-up period (up to 72  h following 
inclusion). In addition, van Genderen et al. [11] recently 
showed that limiting fluid resuscitation in patients with 
a persistent clinical problem (increased lactate levels, low 
urine output, persisting hypotension, etc.) but with nor-
mal peripheral perfusion was safe and associated with 
an improvement in organ function. These findings raise 
some doubts over the whole conception of lactate-guided 
resuscitation.
Consequently a general recommendation to target the 
circulation in patients with increased lactate levels is too 
simplistic and not sufficiently supported by clinical stud-
ies. It seems reasonable to optimize systemic hemody-
namics and microcirculation early in the phase of septic 
shock when there is a clinical problem and markers of 
microcirculatory perfusion are abnormal. In this phase 
several flow-responsive variables will probably improve 
in parallel. After this initial resuscitation, persistently 
elevated lactate levels probably reflect an ongoing sep-
tic process, hyperadrenergia, or metabolic deterioration, 
especially if the other perfusion variables are normal.
In the meantime, whenever lactate levels rise in a septic 
patient, the patient is at increased risk of morbidity and 
mortality. This first requires a thorough investigation into 
the likely causes of this hyperlactatemia. When abnor-
mal tissue perfusion or oxygenation is likely involved, 
optimizing global hemodynamics and microcirculation 
for a short period of time is associated with improved 
outcome.
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